Results 271 to 280 of about 89,537 (296)

Targeting Janus Kinase (JAK) for Fighting Diseases: The Research of JAK Inhibitor Drugs

Current Medicinal Chemistry, 2022
Guo-Wu Rao, Min-Yan Zhao, Wen Zhang
exaly  

Comparison of risks of cancer, infection, and MACEs associated with JAK inhibitor and TNF inhibitor treatment: a multicentre cohort study

Rheumatology, 2023
Tomohisa Uchida, Naoki Iwamoto, Shōichi Fukui   +2 more
exaly  

JAK Inhibitors

2021
openaire   +1 more source

Thromboembolic Adverse Drug Reactions in Janus Kinase (JAK) Inhibitors: Does the Inhibitor Specificity Play a Role?

International Journal of Molecular Sciences, 2021
Przemysław Kotyla, Bartosz Wnuk, Md Asiful Islam   +2 more
exaly  

Management of Alopecia Areata With Topical JAK Inhibitor Therapy: An Evidence-Based Review

Journal of Cutaneous Medicine and Surgery, 2023
Abrahim Abduelmula, Asfandyar Mufti, Jenna Mistry   +2 more
exaly  

The Effect of JAK Inhibitor on the Survival, Anagen Re-Entry, and Hair Follicle Immune Privilege Restoration in Human Dermal Papilla Cells

International Journal of Molecular Sciences, 2020
Jung Eun Kim, Dong Geon Lee, Kwan Ho Jeong   +2 more
exaly  

Optimisation of momelotinib with improved potency and efficacy as pan-JAK inhibitor

Bioorganic and Medicinal Chemistry Letters, 2022
exaly  

Understanding JAK inhibitor toxicity

Journal of the American Academy of Dermatology
Athira, Sivadas, Kevin W, Byram, Manuel, Valdebran, Tyler, Beck   +3 more
openaire   +2 more sources

JAK kinase inhibitors

Drug Discovery Today, 2004
Christopher Burns, Andrew Wilks, Stephen Su   +2 more
openaire   +1 more source

PAN-JAK Inhibitors/Non-selective JAK Inhibitors

Salih Levent Çınar, Fatih Can Aba
openaire   +1 more source